Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort

被引：10

作者：

Casco, Nicolas ^{[1
]}

Levi Jorge, Alberto ^{[1
]}

Juan Palmero, Domingo ^{[1
]}

Alffenaar, Jan-Willem ^{[2
,3
,4
]}

Fox, Greg J. ^{[5
]}

Ezz, Wafaa ^{[5
]}

Cho, Jin-Gun ^{[2
,6
,7
]}

Denholm, Justin ^{[8
,9
]}

Skrahina, Alena ^{[10
]}

Solodovnikova, Varvara ^{[10
]}

Arbex, Marcos Abdo ^{[11
]}

Alves, Tatiana ^{[12
]}

Rabahi, Marcelo Fouad ^{[13
]}

Pereira, Giovana Rodrigues ^{[14
]}

Sales, Roberta ^{[15
]}

Silva, Denise Rossato ^{[16
]}

Saffie, Muntasir M. ^{[17
]}

Escobar Salinas, Nadia ^{[18
]}

Caamano Miranda, Ruth ^{[19
]}

Cisterna, Catalina ^{[19
]}

Concha, Clorinda ^{[19
]}

Fernandez, Israel ^{[19
]}

Villalon, Claudia ^{[19
]}

Guajardo Vera, Carolina ^{[19
]}

Gallegos Tapia, Patricia ^{[19
]}

Cancino, Viviana ^{[20
]}

Carbonell, Monica ^{[20
]}

Cruz, Arturo ^{[20
]}

Munoz, Eduardo ^{[20
]}

Munoz, Camila ^{[20
]}

Navarro, Indira ^{[20
]}

Pizarro, Rolando ^{[20
]}

Cristina Sanchez, Gloria Pereira ^{[20
]}

Vergara Riquelme, Maria Soledad ^{[20
]}

Vilca, Evelyn ^{[20
]}

Soto, Aline ^{[20
]}

Flores, Ximena ^{[21
]}

Garavagno, Ana ^{[21
]}

Hartwig Bahamondes, Martina ^{[21
]}

Moyano Merino, Luis ^{[21
]}

Maria Pradenas, Ana ^{[21
]}

Espinoza Revillot, Macarena ^{[21
]}

Rodriguez, Patricia ^{[21
]}

Serrano Salinas, Angeles ^{[22
]}

Taiba, Carolina ^{[22
]}

Farias Valdes, Joaquin ^{[23
]}

Navarro Subiabre, Jorge ^{[24
]}

Ortega, Carlos ^{[25
]}

Palma, Sofia ^{[26
]}

Perez Castillo, Patricia ^{[27
]}

机构：

[1] Inst Tisioneumonol Prof Dr R Vaccarezza, Buenos Aires, Argentina

[2] Univ Sydney, Sydney Inst Infect Dis, Sydney, Australia

[3] Univ Sydney, Sch Pharm, Fac Med & Hlth, Sydney, Australia

[4] Westmead Hosp, Sydney, Australia

[5] Univ Sydney, Sydney Sch Med, Fac Med & Hlth, Sydney, Australia

[6] Parramatta Chest Clin, Parramatta, Australia

[7] Westmead Hosp, Westmead, Australia

[8] Melbourne Hlth, Victorian TB Program, Melbourne, Vic, Australia

[9] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Infect Dis, Parkville, Australia

[10] Republican Res & Pract Ctr Pulmonol & TB, Minsk, BELARUS

[11] Univ Araraquara, Fac Med, Area Temat Pneumol, Araraquara, Brazil

[12] Univ Fed Bahia, Salvador, Brazil

[13] Univ Fed Goias, Fac Med, Goiania, Go, Brazil

[14] Secretaria Municipal Saude, Lab Municipal Alvorada, Alvorada, Brazil

[15] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Inst Coracao,Div Pneumol, Sao Paulo, Brazil

[16] Univ Fed Rio Grande do Sul UFRGS, Fac Med, Porto Alegre, Brazil

[17] McMaster Univ, Div Respirol, Hamilton, ON, Canada

[18] Minist Salud Chile, Programa Nacl TB, Santiago, Chile

[19] Serv Salud Metropolitano Cent, Santiago, Chile

[20] Serv Salud Metropolitano Sur, Santiago, Chile

[21] Serv Salud Metropolitano Oriente, Providencia, Chile

[22] Serv Salud Metropolitano Occidente, Santiago, Chile

[23] Serv Salud Iquique, Iquique, Chile

[24] Serv Salud Valparaiso San Antonio, Valparaiso, Chile

[25] Serv Salud Concepcion, Concepcion, Chile

[26] Hosp DIPRECA, Las Condes, Chile

[27] Serv Salud Antofagasta, Antofagasta, Chile

[28] Serv Salud Magallanes, Punta Arenas, Chile

[29] Serv Salud Talcahuano, Talcahuano, Chile

[30] Serv Salud Arica, Arica, Chile

[31] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai, Peoples R China

[32] Minist Salud & Protecc Social, Bogota, Colombia

[33] Secretaria Salud Dept, Cauca, Colombia

[34] Univ Cauca, Dept Med Interna, Grp Invest TB, Popayan, Colombia

[35] Catholic Univ Cuenca, Cuenca, Ecuador

[36] WHO Reg Off Eastern Mediterranean Reg, Cairo, Egypt

[37] CHU Amiens Picardie, Resp Dept, Amiens, France

[38] Picardie Jules Verne Univ, UR 4294, AGIR, Amiens, France

[39] Nantes Univ, CHU Nantes, Inst Thorax, Serv Pneumol, Nantes, France

[40] Grp Hosp Sud Ile de France GHSIF, Serv Pneumol, Melun, France

[41] Intermunicipal Hosp Ctr Creteil, Dept Internal Med, Creteil, France

[42] North Cardiol Ctr, Pneumol Dept, St Denis, France

[43] Hop Instruct Armees Percy, Dept Pneumol, Clamart, France

[44] Hop Univ Henri Mondor, AP HP, Unite Pneumol, Creteil, France

[45] Univ Paris Est Creteil, Fac Sante, INSERM, IMRB, Creteil, France

[46] Aristotle Univ Thessaloniki, Pulm Dept, Thessaloniki, Greece

[47] Univ Gamal Abdel Nasser Conakry, CHU Conakry, Fac Sci & Tech Sante, Serv Pneumophtisiol, Conakry, Guinea

[48] Hop Natl Ignace Deen, Conakry, Guinea

[49] Damien Fdn, Conakry, Guinea

[50] Secretaria Salud Honduras, Natl TB Programme, Tegucigalpa, Honduras

来源：

EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷 / 05期

关键词：

EXTREMELY PRETERM; LUNG-FUNCTION; SCHOOL-AGE; BIRTH; EXERCISE; CHILDREN; INFANTS; IMPAIRMENT; SURVIVORS; MEMBRANE;

D O I：

10.1183/13993003.00925-2023

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Background Longitudinal cohort data of patients with tuberculosis (TB) and coronavirus disease 2019 (COVID-19) are lacking. In our global study, we describe long-term outcomes of patients affected by TB and COVID-19. Methods We collected data from 174 centres in 31 countries on all patients affected by COVID-19 and TB between 1 March 2020 and 30 September 2022. Patients were followed-up until cure, death or end of cohort time. All patients had TB and COVID-19; for analysis purposes, deaths were attributed to TB, COVID-19 or both. Survival analysis was performed using Cox proportional risk-regression models, and the log-rank test was used to compare survival and mortality attributed to TB, COVID-19 or both. Results Overall, 788 patients with COVID-19 and TB (active or sequelae) were recruited from 31 countries, and 10.8% (n=85) died during the observation period. Survival was significantly lower among patients whose death was attributed to TB and COVID-19 versus those dying because of either TB or COVID-19 alone (p<0.001). Significant adjusted risk factors for TB mortality were higher age (hazard ratio (HR) 1.05, 95% CI 1.03-1.07), HIV infection (HR 2.29, 95% CI 1.02-5.16) and invasive ventilation (HR 4.28, 95% CI 2.34-7.83). For COVID-19 mortality, the adjusted risks were higher age (HR 1.03, 95% CI 1.02-1.04), male sex (HR 2.21, 95% CI 1.24-3.91), oxygen requirement (HR 7.93, 95% CI 3.44- 18.26) and invasive ventilation (HR 2.19, 95% CI 1.36-3.53). Conclusions In our global cohort, death was the outcome in >10% of patients with TB and COVID-19. A range of demographic and clinical predictors are associated with adverse outcomes.

引用

页数：12

共 50 条

[31] Impact of influenza A co-infection with COVID-19
Agarwal, A.
Agarwal, M.
Sharma, A.
Jakhar, R.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2021, 25 (05) : 413 - 415
[32] COVID-19 co-infection in a patient with brucellosis
Shabani, Shiva
Ghadimi, Saleh
CLINICAL CASE REPORTS, 2022, 10 (09):
[33] Co-infection of COVID-19 and recurrent malaria
Pusparani, Angelita
Henrina, Joshua
Cahyadi, Alius
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2021, 15 (05): : 625 - 629
[34] The (in)significance of TB and COVID-19 co-infection
Khurana, Alkesh Kumar
Aggarwal, Deepak
EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (02)
[35] Meningococcal meningitis and COVID-19 co-infection
Gallacher, Stuart Declan
Seaton, Andrew
BMJ CASE REPORTS, 2020, 13 (08)
[36] Long-term Outcomes After Tracheostomy for COVID-19
Taboada, Manuel
Moreno, Esther
Leal, Sonsoles
Pita-Romero, Rafael
Sanduende, Yolanda
Rama, Pablo
Cid, Milagros
Seoane-Pillado, Teresa
ARCHIVOS DE BRONCONEUMOLOGIA, 2021, 57 : 54 - 56
[37] LONG-TERM GASTROINTESTINAL OUTCOMES POST COVID-19
Niu, Chengu
Zhang, Jing
Zhu, Kaiwen
Bhatta, Prajjwol
Arutla, Venkat
Malik, Sheza
Okolo, Patrick
GASTROENTEROLOGY, 2024, 166 (05) : S950 - S951
[38] TRACHEOSTOMY IN COVID-19 PATIENTS: LONG-TERM OUTCOMES
Mahmood, Syed Nazeer
Chaturvedi, Mansi
Oweis, Emil
Chan, Chee
CRITICAL CARE MEDICINE, 2021, 49 (01) : 136 - 136
[39] Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19 A Binational Cohort Study
Kim, Min Seo
Lee, Hayeon
Lee, Seung Won
Kwon, Rosie
Rhee, Sang Youl
Lee, Jin A.
Koyanagi, Ai
Smith, Lee
Fond, Guillaume
Boyer, Laurent
Lee, Jinseok
Rahmati, Masoud
Shin, Ju-Young
Min, Chanyang
Shin, Jae Il
Yon, Dong Keon
ANNALS OF INTERNAL MEDICINE, 2024, 177 (03) : 291 - 302
[40] Long-Term Outcomes After Tracheostomy for Severe COVID-19: A Retrospective Cohort Study
Swenson, K. E.
Okin, D.
Lai, P. S.
Folch, E. E.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205

← 1 2 3 4 5 →